Evidence map›Paper›PMID 37916886›Full record

ArticleAnnals of clinical and translational neurology2024

Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China.

Linxin Tang, Xuxiong Tang, Qianqian Zhao, Yongchao Li, Yue Bu, Zhen Liu, Jinchen Li, Jifeng Guo, Lu Shen, Hong Jiang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 2 countries.

Linxin TangDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.ORCID 0000-0002-9058-8340
Xuxiong TangDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Qianqian ZhaoDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Yongchao LiDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Yue BuDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Zhen LiuDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Jinchen LiNational Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0003-3335-9303
Jifeng GuoDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Lu ShenDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0002-3393-8578
Hong JiangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0003-2812-4120
Beisha TangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0003-2120-1576
Renshi XuDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Wenfeng CaoDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.
Yanchun YuanDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.ORCID 0009-0007-0384-0717
Junling WangDepartment of Neurology, Xiangya Hospital, Central South University, Jiangxi Hospital, National Regional Center for Neurological Diseases, Nanchang, P. R. China.ORCID 0000-0001-5117-5204
Central South University · CN

Funding

National Key Research and Development Program of China 2021YFA0805202National Natural Science Foundation of China 81300981National Natural Science Foundation of China 81671120National Natural Science Foundation of China 82171431the Project Program of National Clinical Research Center for Geriatric Disorders at Xiangya Hospital 2020LNJJ13the Science and Technology Innovation 2030 STI2030 Major Projects 2021ZD0201803
6 · The paper itself

Abstract

introductionRecently, chloride channel CLIC-like 1 (CLCC1) was reported to be a novel ALS-related gene. We aimed to screen CLCC1 variants in our ALS cohort and further explore the genotype-phenotype correlation of CLCC1-related ALS.

methodsWe screened rare damaging variants in CLCC1 from our cohorts of 1005 ALS patients and 1224 healthy controls with whole-exome sequencing in Central South China. Fisher's exact test was conducted for association analysis at the entire gene level and single variant level.

resultsIn total, four heterozygous missense variants in CLCC1 were identified from four unrelated sporadic ALS patients and predicted to be putative pathogenic by in silico tools and protein model prediction, accounting for 0.40% of all patients (4/1005). The four variants were c.A275C (p.Q92P), c.G1139A (p.R380K), c.C1244T (p.T415M), and c.G1328A (p.R443Q), respectively, which had not been reported in ALS patients previously. Three of four variants were located in exon 10. Patients harboring CLCC1 variants seemed to share a group of similar clinical features, including earlier age at onset, rapid progression, spinal onset, and vulnerable cognitive status. Statistically, we did not find CLCC1 to be associated with the risk of ALS at the entire gene level or single variant level.

conclusionOur findings further expanded the genetic and clinical spectrum of CLCC1-related ALS and provided more genetic evidence for anion channel involvement in the pathogenesis of ALS, but further investigations are needed to verify our findings.

Indexed as

Amyotrophic Lateral SclerosisChinaChloride ChannelsGenetic Association StudiesHumansMutationMutation, MissenseChloride ChannelsCLCC1 protein, human

Identifiers

PMID37916886
PMCPMC10791024
OpenAlexW4388221778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.